Alcon AG | ALC - Gross Profit On Sales

Stock Price
60.74
Daily Change
-0.60 -0.98%
Monthly
-6.03%
Yearly
-26.20%
Q1 Forecast
60.90

Alcon AG reported $1.46B in Gross Profit on Sales for its fiscal quarter ending in September of 2025.





Gross Profit On Sales Change Date
AstraZeneca USD 12.39B 406M Sep/2025
Bayer EUR 5.35B 1.02B Sep/2025
Essilor EUR 8.84B 687M Jun/2025
Fresenius EUR 1.3B 158M Sep/2025
Fresenius Medical Care EUR 1.24B 27M Sep/2025
GlaxoSmithKline GBP 6.18B 106M Dec/2025
GRIFOLS EUR 743.8M 49.13M Jun/2025
Lonza CHF 1.29B 248M Jun/2025
Merck EUR 3.21B 186M Sep/2025
Novartis USD 10.82B 695M Sep/2025
Philips EUR 1.91B 100M Sep/2025
Roche Holding CHF 22.09B 10.04B Dec/2025
Sanofi EUR 8.45B 1.31B Dec/2025
Smith & Nephew USD 2.09B 117M Dec/2025
Sonova Holding CHF 1.28B 205.2M Dec/2025
UCB EUR 2.46B 520M Dec/2024